Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.8300
+0.0100 (1.22%)
At close: Jan 6, 2026, 4:00 PM EST
0.8688
+0.0388 (4.67%)
After-hours: Jan 6, 2026, 5:27 PM EST
Immuron Market Cap
Immuron has a market cap or net worth of $7.67 million as of January 6, 2026. Its market cap has decreased by -37.64% in one year.
Market Cap
7.67M
Enterprise Value
3.80M
1-Year Change
-37.64%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.67M, a decrease of -72.70%. That is a compound annual growth rate of -14.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 4.80M | 6.67% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 950.21B |
| Johnson & Johnson | 494.75B |
| AbbVie | 394.98B |
| UnitedHealth Group | 317.78B |
| AstraZeneca | 293.89B |
| Merck & Co. | 271.11B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |